P-TLS Drug Overview

What Is P-TLS?

P-TLS (para-toluenesulfonamide) is a small-molecule tumor ablation agent developed by Gongwin Biopharm.

Compared with systemic therapies, P-TLS is administered directly to the tumor site, allowing the active ingredient to act locally. Compared with physical ablation approaches, P-TLS is designed to exhibit greater selectivity toward tumor cells while minimizing damage to surrounding normal cells. Its anticancer targets and mechanism of action are distinct from those of conventional anticancer therapies.

P-TLS, also known as para-toluenesulfonamide, is a small-molecule active pharmaceutical ingredient developed by Gongwin Biopharm. It acts directly on tumor cells, initiating irreversible cellular damage and inhibiting further tumor cell proliferation.

At the cellular level, P-TLS disrupts lipid rafts within the cancer cell membrane and interferes with cholesterol recycling, thereby affecting signaling processes associated with cancer cell survival, proliferation, and metastasis. P-TLS also activates autophagic processes and disrupts lysosomal and mitochondrial function, ultimately leading to tumor cell apoptosis and necrosis.

P-TLS Injectable Solution: Key Characteristics

Product specifications and additional pharmaceutical information may be provided here.

How Is P-TLS Administered?

P-TLS is administered by a veterinarian through direct intratumoral injection. Depending on the location and characteristics of the tumor, your dog may require sedation or general anesthesia during the procedure.

For the safety of both your dog and the veterinary medical team, P-TLS administration should always be performed by qualified veterinary professionals in an appropriate veterinary clinical setting.

What Can I Expect During P-TLS Treatment?

The most common local reaction following P-TLS treatment is wound formation at the tumor site, which may occur as the treated tumor tissue undergoes necrosis. The extent and severity of wound formation may vary depending on the tumor and individual patient.

P-TLS is intended to act locally within the tumor while minimizing effects on adjacent healthy tissue.

Your dog may also experience temporary effects associated with sedation or general anesthesia, such as drowsiness, reduced activity, or decreased appetite.

What Are the Possible Side Effects After P-TLS Treatment?

Some of the most commonly observed effects associated with treatment may be related to the use of sedation or general anesthesia. These may include decreased appetite, lethargy, and fatigue.

Pain or swelling may occur at the injection site and may cause temporary discomfort. Your veterinarian may prescribe oral pain medication when clinically appropriate.

Other adverse reactions may also occur. Please consult your veterinarian for further information regarding your dog's individual condition and treatment.

Contact Your Veterinarian Immediately If You Notice:

• Lethargy or fatigue lasting longer than one day
• Excessive pain or lameness
• Vomiting or diarrhea lasting longer than one day
• Difficulty breathing or rapid breathing
• Excessive bleeding, swelling, or ulceration at the injection site
• Any other unusual signs or symptoms that cause concern

Treatment and Recovery

What Is the P-TLS Treatment and Recovery Process?

A course of P-TLS treatment may take approximately 2–3 weeks, depending on the tumor's response to treatment and your dog's overall health condition.

Following tumor necrosis and breakdown, the treated area may undergo a natural wound-healing process. Healthy pink granulation tissue may gradually develop within and around the area of tumor necrosis as part of tissue repair and wound healing.

The duration and appearance of the healing process may vary between individual patients. Your veterinarian will assess the treatment site and provide appropriate wound-care instructions throughout recovery.

Important Care Instructions

How Should I Work With My Veterinarian Before and After P-TLS Treatment?

Your veterinarian may prescribe antibiotics, pain medication, or other supportive medications before or after individual P-TLS treatments when clinically appropriate. Always administer medications exactly as instructed by your veterinarian. If you miss a dose, do not give a double dose unless specifically instructed to do so by your veterinarian.

Daily cleaning and/or dressing of the treatment site may be required. Before handling the wound or changing a dressing, wash your hands thoroughly with soap or an appropriate cleanser and wear disposable gloves.

Clothing, towels, dressings, or other washable materials that have come into contact with the tumor or treatment site should be washed separately from other household laundry.

If your dog attempts to lick, scratch, or rub the treatment site, an Elizabethan collar (E-collar) or an appropriate protective dressing may be necessary. Please contact your veterinarian for advice if you notice changes in the wound or if your dog repeatedly interferes with the treatment site.